Increased Malonyl-CoA Levels in Muscle From Obese and Type 2 Diabetic Subjects Lead to Decreased Fatty Acid Oxidation and Increased Lipogenesis; Thiazolidinedione Treatment Reverses These Defects
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Increased accumulation of fatty acids and their derivatives can impair insulin-stimulated glucose disposal by skeletal muscle. To characterize the nature of the defects in lipid metabolism and to evaluate the effects of thiazolidinedione treatment, we analyzed the levels of triacylglycerol, long-chain fatty acyl-coA, malonyl-CoA, fatty acid oxidation, AMP-activated protein kinase (AMPK), acetyl-CoA carboxylase (ACC), malonyl-CoA decarboxylase, and fatty acid transport proteins in muscle biopsies from nondiabetic lean, obese, and type 2 subjects before and after an euglycemic-hyperinsulinemic clamp as well as pre–and post–3-month rosiglitazone treatment. We observed that low AMPK and high ACC activities resulted in elevation of malonyl-CoA levels and lower fatty acid oxidation rates. These conditions, along with the basal higher expression levels of fatty acid transporters, led accumulation of long-chain fatty acyl-coA and triacylglycerol in insulin-resistant muscle. During the insulin infusion, muscle fatty acid oxidation was reduced to a greater extent in the lean compared with the insulin-resistant subjects. In contrast, isolated muscle mitochondria from the type 2 subjects exhibited a greater rate of fatty acid oxidation compared with the lean group. All of these abnormalities in the type 2 diabetic group were reversed by rosiglitazone treatment. In conclusion, these studies have shown that elevated malonyl-CoA levels and decreased fatty acid oxidation are key abnormalities in insulin-resistant muscle, and, in type 2 diabetic patients, thiazolidinedione treatment can reverse these abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The concentration of IMTG, fatty acyl-CoAs, DAG, and/or ceramide are elevated in skeletal muscle from obese humans, genetically obese rats, and HFD-fed, obese mice in association with insulin resistance (53)(54)(55)(56)(57).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [56]
Experimental — accuracy not yet measuredIn the citing paper
“Thus, clinical studies have demonstrated that obese, insulin-resistant, and type 2 diabetic individuals do not exhibit a reduced capacity to oxidize fatty acids (73,74) and have normal, or even increased, mitochondrial function, as compared with lean controls (56,75).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 1×
“This could have subsequent deleterious effects through oxidative damage (39,55,56).”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Srere, P. A. (1969) · Methods in Enzymology · doi:10.1016/0076-6879(69)13005-0 · Cited by 2,005
Kelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096
Tomas, E., Tsao, T.-S., Saha, A. K., Murrey, H. E., Zhang, C. C., Itani, S. I., Lodish, H. F., & Ruderman, N. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222657499 · Cited by 973
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887
Winder, W. W., & Hardie, D. G. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.2.e299 · Cited by 799
Yu, J. G., Javorschi, S., Hevener, A. L., Kruszynska, Y. T., Norman, R. A., Sinha, M., & Olefsky, J. M. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2968 · Cited by 725
Self-citationMalonyl-CoA, fuel sensing, and insulin resistance
Ruderman, N. B., Saha, A. K., Vavvas, D., & Witters, L. A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.1.e1 · Cited by 650
Cited by
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
Insulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
Self-citationRegulation of mitochondrial biogenesis
Jornayvaz, F. R., & Shulman, G. I. (2010) · Essays in Biochemistry · doi:10.1042/bse0470069 · Cited by 1,119
“Indeed, a study showed that rosiglitazone increased AMPK activity in muscle in Type 2 diabetes and obesity [59].”
BackgroundAMPK and SIRT1: a long-standing partnership?
Ruderman, N. B., Julia Xu, X., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, F., & Ido, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00745.2009 · Cited by 903
AMPK, insulin resistance, and the metabolic syndrome
Ruderman, N. B., Carling, D., Prentki, M., & Cacicedo, J. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67227 · Cited by 873
Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2010) · Physiological Reviews · doi:10.1152/physrev.00003.2009 · Cited by 751
The role of mitochondria in insulin resistance and type 2 diabetes mellitus
Szendroedi, J., Phielix, E., & Roden, M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.138 · Cited by 600
Mitochondrial dysfunction and insulin resistance: an update
Montgomery, M. K., & Turner, N. (2015) · Endocrine Connections · doi:10.1530/ec-14-0092 · Cited by 527
AMPK in skeletal muscle function and metabolism
Kjøbsted, R., Hingst, J. R., Fentz, J., Foretz, M., Sanz, M., Pehmøller, C., Shum, M., Marette, A., Mounier, R., Treebak, J. T., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700442r · Cited by 496
AMPK and the biochemistry of exercise: implications for human health and disease
Richter, E. A., & Ruderman, N. B. (2009) · Biochemical Journal · doi:10.1042/bj20082055 · Cited by 481
AMPK activation: a therapeutic target for type 2 diabetes?
Saha, A., Coughlan, K., Valentine, R., & Ruderman, N. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s43731 · Cited by 429
Steinberg, G. R., Michell, B. J., van Denderen, B. J. W., Watt, M. J., Carey, A. L., Fam, B. C., Andrikopoulos, S., Proietto, J., Görgün, C. Z., Carling, D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.11.005 · Cited by 417
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 385
AMPK As a Metabolic Tumor Suppressor: Control of Metabolism and Cell Growth
Luo, Z., Zang, M., & Guo, W. (2010) · Future Oncology · doi:10.2217/fon.09.174 · Cited by 383
The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia
Sylow, L., Tokarz, V. L., Richter, E. A., & Klip, A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.020 · Cited by 366
Meyer, M. R., Clegg, D. J., Prossnitz, E. R., & Barton, M. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02237.x · Cited by 332
Ribas, V., Nguyen, M. T. A., Henstridge, D. C., Nguyen, A.-K., Beaven, S. W., Watt, M. J., & Hevener, A. L. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00504.2009 · Cited by 309
Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier
Divakaruni, A. S., Wiley, S. E., Rogers, G. W., Andreyev, A. Y., Petrosyan, S., Loviscach, M., Wall, E. A., Yadava, N., Heuck, A. P., Ferrick, D. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303360110 · Cited by 308
MitoNEET is a uniquely folded 2Fe–2S outer mitochondrial membrane protein stabilized by pioglitazone
Paddock, M. L., Wiley, S. E., Axelrod, H. L., Cohen, A. E., Roy, M., Abresch, E. C., Capraro, D., Murphy, A. N., Nechushtai, R., Dixon, J. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707189104 · Cited by 302
Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction
Khodabandehloo, H., Gorgani-Firuzjaee, S., Panahi, G., & Meshkani, R. (2016) · Translational Research · doi:10.1016/j.trsl.2015.08.011 · Cited by 295
Cardiolipin Remodeling by ALCAT1 Links Oxidative Stress and Mitochondrial Dysfunction to Obesity
Li, J., Romestaing, C., Han, X., Li, Y., Hao, X., Wu, Y., Sun, C., Liu, X., Jefferson, L. S., Xiong, J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.07.003 · Cited by 295
Ritov, V. B., Menshikova, E. V., Azuma, K., Wood, R., Toledo, F. G. S., Goodpaster, B. H., Ruderman, N. B., & Kelley, D. E. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00317.2009 · Cited by 283
Corpeleijn, E., Saris, W. H. M., & Blaak, E. E. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00544.x · Cited by 280
“Malonyl-CoA was elevated in muscle biopsies from obese and obese T2D subjects, when compared with lean controls (17), although in another study malonyl-CoA was not significantly reduced in obese T2D subjects compared with overweight controls (18).”
ResultLai, Y.-C., Tabima, D. M., Dube, J. J., Hughan, K. S., Vanderpool, R. R., Goncharov, D. A., St. Croix, C. M., Garcia-Ocaña, A., Goncharova, E. A., Tofovic, S. P., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.018935 · Cited by 270
Li, P., Fan, W., Xu, J., Lu, M., Yamamoto, H., Auwerx, J., Sears, D. D., Talukdar, S., Oh, D., Chen, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.050 · Cited by 266
Self-citationObesity May Accelerate the Aging Process
Salvestrini, V., Sell, C., & Lorenzini, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00266 · Cited by 260
“In addition, some studies demonstrated the impairment of AMPK activation in skeletal muscle of individuals with obesity and diabetes (110, 111), and in visceral adipose tissue of centrally obese humans with Cushings syndrome, a disorder associated with insulin resistance (112).”
BackgroundZhang, L., Keung, W., Samokhvalov, V., Wang, W., & Lopaschuk, G. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.014 · Cited by 257
Protein acylation: mechanisms, biological functions and therapeutic targets
Shang, S., Liu, J., & Hua, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01245-y · Cited by 235
Xu, X. J., Gauthier, M.-S., Hess, D. T., Apovian, C. M., Cacicedo, J. M., Gokce, N., Farb, M., Valentine, R. J., & Ruderman, N. B. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p022905 · Cited by 229
Lu, M., Sarruf, D. A., Talukdar, S., Sharma, S., Li, P., Bandyopadhyay, G., Nalbandian, S., Fan, W., Gayen, J. R., Mahata, S. K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2332 · Cited by 227
Self-citationIncreased skeletal muscle ceramide level in men at risk of developing type 2 diabetes
Straczkowski, M., Kowalska, I., Baranowski, M., Nikolajuk, A., Otziomek, E., Zabielski, P., Adamska, A., Blachnio, A., Gorski, J., & Gorska, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0781-2 · Cited by 218
Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases
Yao, W., Hu, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01918-w · Cited by 208
Free fatty acids and skeletal muscle insulin resistance
Kraegen, E. W., & Cooney, G. J. (2008) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000319118.44995.9a · Cited by 206
Maternal Obesity, Inflammation, and Fetal Skeletal Muscle Development1
Du, M., Yan, X., Tong, J. F., Zhao, J., & Zhu, M. J. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.109.077099 · Cited by 204
Li, W., Li, F., Zhang, X., Lin, H.-K., & Xu, C. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00825-8 · Cited by 198
Nickerson, J. G., Alkhateeb, H., Benton, C. R., Lally, J., Nickerson, J., Han, X.-X., Wilson, M. H., Jain, S. S., Snook, L. A., Glatz, J. F. C., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.004788 · Cited by 197
Fouladi, F., Bailey, M. J., Patterson, W. B., Sioda, M., Blakley, I. C., Fodor, A. A., Jones, R. B., Chen, Z., Kim, J. S., Lurmann, F., et al. (2020) · Environment International · doi:10.1016/j.envint.2020.105604 · Cited by 195
Colak, G., Pougovkina, O., Dai, L., Tan, M., te Brinke, H., Huang, H., Cheng, Z., Park, J., Wan, X., Liu, X., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.048850 · Cited by 190
Zhu, M. J., Han, B., Tong, J., Ma, C., Kimzey, J. M., Underwood, K. R., Xiao, Y., Hess, B. W., Ford, S. P., Nathanielsz, P. W., et al. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.149633 · Cited by 181
Tuning fatty acid oxidation in skeletal muscle with dietary fat and exercise
Fritzen, A. M., Lundsgaard, A.-M., & Kiens, B. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0405-1 · Cited by 180
Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity
Moro, C., Bajpeyi, S., & Smith, S. R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00624.2007 · Cited by 179
O’Neill, H. M., Lally, J., Galić, S., Thomas, M. M., Azizi, P. D., Fullerton, M. D., Smith, B. K., Pulinilkunnil, T., Chen, Z., Samaan, M. C., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3273-1 · Cited by 179
Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization
Sears, D. D., Hsiao, G., Hsiao, A., Yu, J. G., Courtney, C. H., Ofrecio, J. M., Chapman, J., & Subramaniam, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903032106 · Cited by 177
Self-citationRegulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals
Holloway, G. P., Bonen, A., & Spriet, L. L. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26717b · Cited by 174
Insulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 173
Nicolai, A., Li, M., Kim, D. H., Peterson, S. J., Vanella, L., Positano, V., Gastaldelli, A., Rezzani, R., Rodella, L. F., Drummond, G., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.124701 · Cited by 170
Negative regulation of AMPK signaling by high glucose via E3 ubiquitin ligase MG53
Jiang, P., Ren, L., Zhi, L., Yu, Z., Lv, F., Xu, F., Peng, W., Bai, X., Cheng, K., Quan, L., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.12.008 · Cited by 168
The role of skeletal muscle Akt in the regulation of muscle mass and glucose homeostasis
Jaiswal, N., Gavin, M. G., Quinn, W. J., Luongo, T. S., Gelfer, R. G., Baur, J. A., & Titchenell, P. M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.001 · Cited by 167
Splicing factor SRSF3 is crucial for hepatocyte differentiation and metabolic function
Sen, S., Jumaa, H., & Webster, N. J. G. (2013) · Nature Communications · doi:10.1038/ncomms2342 · Cited by 167
Is mitochondrial dysfunction a cause of insulin resistance?
Turner, N., & Heilbronn, L. K. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.08.001 · Cited by 164
Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study
Sun, L., Liang, L., Gao, X., Zhang, H., Yao, P., Hu, Y., Ma, Y., Wang, F., Jin, Q., Li, H., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0232 · Cited by 164
Hey‐Mogensen, M., Højlund, K., Vind, B. F., Wang, L., Dela, F., Beck‐Nielsen, H., Fernström, M., & Sahlin, K. (2010) · Diabetologia · doi:10.1007/s00125-010-1813-x · Cited by 160
Coletta, D. K., Sriwijitkamol, A., Wajcberg, E., Tantiwong, P., Li, M., Prentki, M., Murthy, M. S., Jenkinson, C. P., Cersósimo, E., Musi, N., et al. (2009) · Diabetologia · doi:10.1007/s00125-008-1256-9 · Cited by 159
Højlund, K., Glintborg, D., Andersen, N. R., Birk, J. B., Treebak, J. T., Frøsig, C., Beck‐Nielsen, H., & Wojtaszewski, J. F. P. (2007) · Diabetes · doi:10.2337/db07-0706 · Cited by 156
Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress
Spahis, S., Borys, J.-M., & Levy, E. H. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6756 · Cited by 150
Holloway, G. P., Thrush, A. B., Heigenhauser, G. J. F., Tandon, N. N., Dyck, D. J., Bonen, A., & Spriet, L. L. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00639.2006 · Cited by 147
AMPK‐independent pathways regulate skeletal muscle fatty acid oxidation
Dzamko, N., Schertzer, J. D., Ryall, J. G., Steel, R., Macaulay, S. L., Wee, S., Chen, Z., Michell, B. J., Oakhill, J. S., Watt, M. J., et al. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.159814 · Cited by 147
Du, Y., Cai, T., Li, T., Xue, P., Zhou, B., He, X., Peng, W., Liu, P., Yang, F., & Wei, T. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.041947 · Cited by 144
Exercise-induced AMPK activity in skeletal muscle: Role in glucose uptake and insulin sensitivity
Friedrichsen, M., Mortensen, B., Pehmøller, C., Birk, J. B., & Wojtaszewski, J. F. P. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.013 · Cited by 143
Skeletal muscle energy metabolism in obesity
Mengeste, A. M., Rustan, A. C., & Lund, J. (2021) · Obesity · doi:10.1002/oby.23227 · Cited by 141
“Therefore, in obesity, metabolic capacity of skeletal muscle appears to be organized toward fatty acid (FA) esterification and storage rather than oxidation (25,31,32).”
BackgroundContribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview
Holloway, G. P., Luiken, J. J. F. P., Glatz, J. F. C., Spriet, L. L., & Bonen, A. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01878.x · Cited by 140
The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity
Chen, H.-H., Tseng, Y. J., Wang, S.-Y., Tsai, Y.-S., Chang, C.-S., Tc, K., Yao, W.-J., Shieh, C. ‐., Wu, C.-H., & Kuo, P.-H. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.65 · Cited by 138
Høeg, L. D., Sjøberg, K. A., Jeppesen, J., Jensen, T. E., Frøsig, C., Birk, J. B., Bisiani, B., Hiscock, N., Pilegaard, H., Wojtaszewski, J. F. P., et al. (2011) · Diabetes · doi:10.2337/db10-0698 · Cited by 136
“AMPK is an important energy sensor in skeletal muscle and a decrease in its activity and/or protein expression in muscle has been found in several rodent models of insulin resistance (29) as well as in some (30) but not all (31) studies of type 2 diabetic patients.”
Schenk, S., Harber, M. P., Shrivastava, C. R., Burant, C., & Horowitz, J. F. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.175489 · Cited by 136
Mitochondrial Dysfunction in Type 2 Diabetes and Obesity
Højlund, K., Mogensen, M., Sahlin, K., & Beck-Nielsen, H. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.006 · Cited by 135
Wu, W.-C., Feng, J., Jiang, D., Zhou, X., Jiang, Q. L., Cai, M., Wang, X., Shan, T., & Wang, Y. (2017) · Scientific Reports · doi:10.1038/srep41606 · Cited by 128
Mellor, C. L., Steinmetz, F. P., & Cronin, M. (2015) · Critical Reviews in Toxicology · doi:10.3109/10408444.2015.1089471 · Cited by 127
Shi, Y. (2010) · Journal of Biomedical Research · doi:10.1016/s1674-8301(10)60003-6 · Cited by 125
Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside
Gariani, K., Philippé, J., & Jornayvaz, F. R. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.11.002 · Cited by 122
Holloway, G. P., Benton, C. R., Mullen, K. L., Yoshida, Y., Snook, L. A., Han, X.-X., Glatz, J. F. C., Luiken, J. J. F. P., Lally, J., Dyck, D. J., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90896.2008 · Cited by 119
The Landscape of Histone Modifications in a High-Fat Diet-Induced Obese (DIO) Mouse Model
Nie, L., Shuai, L., Zhu, M., Liu, P., Xie, Z., Jiang, S., Jiang, H., Li, J., Zhao, Y., Li, J.-Y., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m117.067553 · Cited by 119
Aguer, C., Mercier, J. G., Man, C. Y. W., Metz, L., Bordenave, S., Lambert, K., Jean, E., Lantier, L., Bounoua, L., Brun, J. ‐., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1708-x · Cited by 118
Obesity and Cancer Progression: Is There a Role of Fatty Acid Metabolism?
Balaban, S., Lee, L. S., Schreuder, M., & Hoy, A. J. (2015) · BioMed Research International · doi:10.1155/2015/274585 · Cited by 113
Heme oxygenase: the key to renal function regulation
Abraham, N. G., Cao, J. J., Sacerdoti, D., Li, X., & Drummond, G. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90449.2008 · Cited by 107
Andreasen, A. S., Kelly, M., Berg, R. M. G., Møller, K., & Pedersen, B. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023999 · Cited by 107
The Role of AMP-Activated Protein Kinase in Obesity
Kola, B., Grossman, A. B., & Korbonits, M. (2008) · KARGER eBooks · doi:10.1159/000115366 · Cited by 106
AMP-activated protein kinase and adipogenesis in sheep fetal skeletal muscle and 3T3-L1 cells1
Tong, J., Zhu, M. J., Underwood, K. R., Hess, B. W., Ford, S. P., & Du, . (2008) · Journal of Animal Science · doi:10.2527/jas.2007-0794 · Cited by 103
AMPK‐dependent hormonal regulation of whole‐body energy metabolism
Dzamko, N. L., & Steinberg, G. R. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01969.x · Cited by 99
Kola, B., Christ‐Crain, M., Lolli, F., Arnaldi, G., Giacchetti, G., Boscaro, M., Grossman, A. B., & Korbonits, M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1297 · Cited by 97
Jain, S. S., Chabowski, A., Snook, L. A., Schwenk, R. W., Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.06.020 · Cited by 96
Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome
Shukla, P., & Mukherjee, S. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.02.006 · Cited by 96
Function and Mechanism of Novel Histone Posttranslational Modifications in Health and Disease
Xu, H., Wu, M., Ma, X., Huang, W. G., & Xu, Y. (2021) · BioMed Research International · doi:10.1155/2021/6635225 · Cited by 96
Fraser, S. A., Gimenez-Lopez, I., Cook, N., Jennings, I. G., Katerelos, M., Katsis, F., Levidiotis, V., Kemp, B. E., & Power, D. A. (2007) · Biochemical Journal · doi:10.1042/bj20061850 · Cited by 95
Four days of simulated shift work reduces insulin sensitivity in humans
Bescós, R., Boden, M. J., Jackson, M. L., Trewin, A. J., Marin, E. C., Levinger, I., GARNHAM, A. P., Hiam, D., Falcão‐Tebas, F., Conte, F., et al. (2018) · Acta Physiologica · doi:10.1111/apha.13039 · Cited by 92
Hafizi Abu Bakar, M., Kian Kai, C., Wan Hassan, W. N., Sarmidi, M. R., Yaakob, H., & Zaman Huri, H. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2601 · Cited by 91
SIRT5 deacylates metabolism-related proteins and attenuates hepatic steatosis in ob/ob mice
Du, Y., Hu, H., Qu, S., Wang, J., Hua, C., Zhang, J., Wei, P., He, X., Hao, J., Liu, P., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.037 · Cited by 90
Guerra, B., Guadalupe‐Grau, A., Fuentes, T., Ponce‐González, J. G., Morales‐Álamo, D., Olmedillas, H., Guillén, J. Á., Santana, A., & Calbet, J. A. L. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1413-y · Cited by 90
Skov, V., Glintborg, D., Knudsen, S., Tan, Q., Jensen, T. E., Kruse, T. A., Beck‐Nielsen, H., & Højlund, K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002466 · Cited by 89
Targeting Heme Oxygenase: Therapeutic Implications for Diseases of the Cardiovascular System
Peterson, S. J., Frishman, W. H., & Abraham, N. G. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e31819d813a · Cited by 88
Biochemical Competition Makes Fatty-Acid β-Oxidation Vulnerable to Substrate Overload
van Eunen, K., Simons, S. M. J., Gerding, A., Bleeker, A., den Besten, G., Volker‐Touw, C. M. L., Houten, S. M., Groen, A. K., Krab, K., Reijngoud, D., et al. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003186 · Cited by 87
Insulin resistance and fuel homeostasis: the role of AMP‐activated protein kinase
Hegarty, B. D., Turner, N. A., Cooney, G. J., & Kraegen, E. W. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01968.x · Cited by 86
Viscarra, J. A., & Ortiz, R. M. (2013) · Metabolism · doi:10.1016/j.metabol.2012.12.014 · Cited by 83
Changes in adiponectin, its receptors and AMPK activity in tissues of diet-induced diabetic mice
Bonnard, C., Durand, A., Vidal, H., & Rieusset, J. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.09.006 · Cited by 82
Bandyopadhyay, G. K., Vu, C. U., Gentile, S., Lee, H., Biswas, N., Chi, N., O’Connor, D. T., & Mahata, S. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.335877 · Cited by 81
Self-citationHøjlund, K., Birk, J. B., Klein, D. K., Levin, K., Rose, A. J., Hansen, B. F., Nielsen, J. N., Beck‐Nielsen, H., & Wojtaszewski, J. F. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0897 · Cited by 80
Murase, T., Yokoi, Y., Misawa, K., Ominami, H., Suzuki, Y., Shibuya, Y., & Hase, T. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511005083 · Cited by 79
Nutrient Excess in AMPK Downregulation and Insulin Resistance.
Coughlan, K. A., Valentine, R. J., Ruderman, N. B., & Saha, A. K. (2013) · PubMed · Cited by 78
Laye, M. J., Rector, R. S., Borengasser, S. J., Naples, S. P., Uptergrove, G. M., Ibdah, J. A., Booth, F. W., & Thyfault, J. P. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91186.2008 · Cited by 77
The impact of bed rest on human skeletal muscle metabolism
Eggelbusch, M., Charlton, B. T., Bosutti, A., Ganse, B., Giakoumaki, I., Grootemaat, A. E., Hendrickse, P. W., Jaspers, Y. R. J., Kemp, S., Kerkhoff, T. J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101372 · Cited by 77
Genome-wide gene expression profiling in children with non-obese obstructive sleep apnea
Khalyfa, A., Capdevila, Ó. S., Buazza, M., Serpero, L. D., Gozal, D., & Gozal, D. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2007.11.006 · Cited by 77
Metadata
- Authors
- Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J., & Olefsky, J. M.
- Affiliations
- University of California San Diego (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2006-08-01
- Volume
- 55
- Issue
- 8
- Pages
- 2277-2285
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2110549950
- Cited by
- 291
- References
- 62
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 7 · 2023: 2 · 2022: 9 · 2021: 12 · 2020: 17 · 2019: 10 · 2018: 7 · 2017: 11 · 2016: 14 · 2015: 13 · 2014: 17 · 2013: 16 · 2012: 14
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Diabetes (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCLA - Biblioteca de Ciencias de la Salud (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-33651, DK-16964)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- malonyl-CoA, fatty acid oxidation, lipogenesis, type 2 diabetes, obesity, insulin resistance, skeletal muscle, AMPK, acetyl-CoA carboxylase, fatty acid transporters, triglyceride accumulation, rosiglitazone, thiazolidinediones, mitochondrial fatty acid oxidation, insulin-stimulated glucose disposal
- MeSH terms
- Rosiglitazone, Acetyl-CoA Carboxylase, Acyl Coenzyme A, Adult, Carboxy-Lyases, Diabetes Mellitus, Type 2, Fatty Acids, Female, Humans, Hypoglycemic Agents, Insulin Resistance, Lipids, Male, Malonyl Coenzyme A, Middle Aged, Mitochondria, Muscle, Multienzyme Complexes, Obesity, Oxidation-Reduction, Triglycerides, Glucose Clamp Technique, Protein Serine-Threonine Kinases, Muscle, Skeletal, Thiazolidinediones, Fatty Acid Transport Proteins, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.